SOPHiA GENETICS SA·4

Apr 21, 4:04 PM ET

Van Well Daan 4

Research Summary

AI-generated summary

Updated

SOPHiA GENETICS (SOPH) Chief Legal Officer Daan Van Well Sells 684 Shares

What Happened

  • Daan Van Well, Chief Legal Officer of SOPHiA GENETICS SA (SOPH), sold 684 shares on April 20, 2026.
  • The reported weighted-average price was $5.20 per share (range $5.10–$5.29), for total proceeds of approximately $3,554. This was a sale (not a purchase) and was executed to satisfy tax withholding obligations related to the vesting of restricted stock units.

Key Details

  • Transaction date: 2026-04-20; Filing date (Form 4): 2026-04-21 (timely).
  • Transaction type/code: Sale (S).
  • Shares sold: 684; Weighted-average price: $5.20; Price range: $5.10–$5.29.
  • Reported reason: Shares sold in the open market to satisfy tax withholding on RSUs that vested April 18, 2026 (Footnote F1).
  • Trading plan: Sales were effected under a pre-established Rule 10b5-1(c) trading plan and were non-discretionary (Footnote F1).
  • Additional note: The filer reports a weighted-average price and offers to provide per-price breakdown on request (Footnote F2).
  • Shares owned after the transaction: Not stated in this filing.

Context

  • These sales were routine tax-withholding dispositions of vested RSUs under a 10b5-1 plan, which typically do not signal discretionary insider selling. The dollar amount is modest (~$3.6k) relative to company-market activity.